Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › WI › MILWAUKEE › WISCONSIN DIAGNOSTIC LABORATORIES LLC

WISCONSIN DIAGNOSTIC LABORATORIES LLC

NPI: 1932109675 · MILWAUKEE, WI 53226 · Clinical Medical Laboratory · NPI assigned 07/22/2005

$22.72M
Total Medicaid Paid
1,381,402
Total Claims
1,192,550
Beneficiaries
253
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialHERBNER, ROBIN (CFO)
NPI Enumeration Date07/22/2005

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 129,901 $1.98M
2019 217,005 $2.77M
2020 207,884 $3.60M
2021 216,056 $4.47M
2022 212,125 $3.76M
2023 200,580 $3.12M
2024 197,851 $3.02M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r 58,533 51,396 $4.33M
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 57,944 52,875 $1.62M
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 52,929 49,287 $1.47M
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B 14,062 12,815 $1.27M
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 29,257 27,079 $725K
81420 Fetal chromosomal aneuploidy genomic sequence analysis panel 1,610 1,480 $711K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 27,267 25,364 $519K
86481 6,823 6,275 $456K
80061 Lipid panel 43,875 40,886 $433K
87536 5,939 5,469 $430K
80053 Comprehensive metabolic panel 52,285 45,120 $403K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 28,554 25,700 $386K
86480 7,353 6,973 $379K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 12,033 11,413 $372K
80050 General health panel 9,565 8,621 $351K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 17,400 16,200 $349K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types 12,369 11,743 $336K
84443 Thyroid stimulating hormone (TSH) 28,033 25,873 $324K
83655 29,759 28,376 $321K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 54,348 39,238 $300K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV 2,931 2,716 $298K
86803 24,970 23,335 $268K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 6,876 5,608 $246K
G0145 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision 12,713 12,003 $244K
80048 Basic metabolic panel (calcium, ionized) 37,944 26,131 $224K
83036 Hemoglobin; glycosylated (A1C) 33,305 31,015 $223K
87529 7,709 6,190 $210K
87086 Culture, bacterial; quantitative colony count, urine 31,739 29,131 $197K
81220 CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants 1,149 1,074 $189K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 4,868 3,740 $187K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 2,541 2,339 $169K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 8,170 7,397 $166K
80081 2,961 2,477 $158K
88305 Level IV - Surgical pathology, gross and microscopic examination 6,116 4,811 $150K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 5,019 3,637 $137K
87077 17,534 15,189 $130K
82728 11,600 10,931 $119K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer 4,822 4,527 $109K
85027 20,915 18,943 $105K
82607 10,098 9,430 $104K
87088 16,378 15,125 $104K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 2,346 2,248 $104K
86592 30,767 28,562 $103K
86360 2,494 2,290 $102K
87186 12,722 11,326 $86K
84403 4,618 4,243 $84K
83013 1,656 1,596 $82K
87522 Neg quan hep c or qual rna 2,615 2,388 $81K
86359 2,497 2,291 $79K
83970 3,218 2,938 $79K
87340 10,360 9,590 $79K
81329 1,010 960 $74K
86762 6,473 6,027 $69K
85018 30,595 29,271 $66K
84439 9,676 8,964 $66K
80074 2,304 2,092 $58K
84146 3,921 3,592 $58K
83516 6,180 2,970 $57K
83880 2,395 2,116 $56K
82746 5,362 5,006 $54K
84702 4,594 3,623 $53K
83001 3,832 3,592 $51K
82670 2,836 2,628 $50K
82951 3,941 3,695 $46K
85610 15,274 6,225 $46K
87081 8,122 7,698 $45K
86038 4,637 4,287 $42K
83550 6,623 6,214 $42K
83735 7,945 5,222 $38K
83540 7,962 7,434 $38K
87563 2,048 1,901 $37K
87210 9,326 8,680 $37K
82043 9,473 8,873 $37K
87801 Infectious agent detection by nucleic acid; amplified probe, multiple organisms 1,225 1,135 $35K
86140 8,931 6,346 $35K
86706 4,309 3,969 $35K
87070 5,193 4,787 $35K
87493 1,446 1,303 $35K
83021 2,430 2,249 $35K
87631 360 332 $33K
80076 5,268 4,520 $32K
81001 13,575 12,348 $31K
84481 2,749 2,520 $31K
86618 2,071 1,287 $31K
82274 2,386 2,219 $29K
99001 9,382 4,759 $29K
86850 6,771 6,317 $28K
86003 1,050 755 $28K
82105 2,340 2,188 $27K
80197 3,004 1,828 $26K
86696 1,613 1,484 $25K
86787 3,167 2,773 $25K
80164 2,392 1,896 $24K
84460 5,172 4,542 $24K
83002 1,783 1,650 $23K
82533 1,969 1,479 $21K
82627 1,510 1,359 $20K
0202U Oncology (prostate), multianalyte, gene expression profiling 974 910 $19K
G0472 Hepatitis c antibody screening, for individual at high risk and other covered indication(s) 6,098 5,739 $18K
84153 1,599 1,464 $18K
82677 1,008 916 $18K
82024 731 636 $17K
82950 4,216 3,951 $17K
G0103 Prostate cancer screening; prostate specific antigen test (psa) 1,300 1,193 $17K
84100 4,573 3,048 $17K
83525 2,006 1,755 $16K
86695 1,345 1,254 $16K
86376 1,626 1,415 $15K
86780 1,730 1,619 $15K
87450 1,852 1,669 $15K
86900 6,613 6,106 $14K
86901 6,198 5,774 $14K
82784 1,781 1,136 $13K
86336 1,003 910 $13K
87521 Neg quan hep c or qual rna 572 531 $13K
86431 2,953 2,756 $12K
87902 61 54 $12K
82652 634 583 $12K
86235 851 173 $12K
86160 1,102 692 $11K
88112 341 327 $11K
87338 911 859 $11K
87209 845 762 $11K
86704 1,198 1,105 $11K
86800 1,059 910 $11K
83090 880 769 $10K
83690 2,006 1,873 $10K
87046 1,435 1,291 $10K
86765 1,167 899 $10K
86735 914 681 $10K
87045 1,431 1,289 $10K
84270 742 692 $10K
82947 3,072 2,912 $10K
87205 3,014 2,763 $10K
84550 2,987 2,747 $10K
82565 2,650 1,738 $10K
86705 1,178 1,082 $10K
82570 2,408 2,171 $9K
87634 249 223 $9K
80055 509 472 $9K
82550 1,845 1,281 $9K
85652 4,286 3,342 $8K
86708 787 733 $8K
86769 307 291 $8K
84402 484 446 $8K
87808 794 752 $7K
84450 1,727 1,593 $7K
86694 553 508 $7K
86200 846 787 $7K
84425 608 575 $7K
86225 763 679 $7K
82248 1,563 1,121 $6K
86334 492 446 $6K
84156 2,308 2,099 $6K
82785 745 676 $6K
85730 1,251 1,176 $6K
83520 560 508 $5K
85045 1,806 1,686 $5K
87177 814 725 $5K
80178 1,062 690 $5K
84165 754 695 $5K
80165 559 410 $5K
36415 Collection of venous blood by venipuncture 87,356 63,798 $5K
85651 1,494 972 $5K
83993 343 315 $4K
83014 631 608 $4K
82330 425 373 $4K
86593 1,033 932 $4K
87101 420 404 $3K
87206 649 598 $3K
83498 180 174 $3K
82977 489 430 $3K
87632 15 13 $3K
87901 12 12 $3K
85007 1,029 886 $3K
P9603 Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled 10,059 5,655 $3K
86709 334 318 $3K
82465 588 580 $2K
87106 302 263 $2K
82140 208 133 $2K
82247 512 375 $2K
84144 186 162 $2K
P9604 Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge 7,843 3,821 $2K
80202 146 49 $2K
82952 619 597 $2K
87147 460 426 $2K
84132 482 337 $2K
G0471 Collection of venous blood by venipuncture or urine sample by catheterization from an individual in a skilled nursing facility (snf) or by a laboratory on behalf of a home health agency (hha) 5,290 2,480 $2K
G0432 Infectious agent antibody detection by enzyme immunoassay (eia) technique, hiv-1 and/or hiv-2, screening 11,383 10,783 $2K
88342 105 84 $2K
G0476 Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test 1,669 1,559 $2K
87497 64 40 $2K
87900 12 12 $2K
G0123 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision 77 75 $1K
87427 98 92 $1K
82150 223 195 $1K
84154 79 73 $993.22
84630 167 158 $935.58
84134 150 140 $912.33
87184 158 151 $898.12
82239 89 77 $838.79
83615 178 136 $774.55
80175 65 63 $699.52
84480 59 52 $652.81
87107 48 44 $641.21
85246 24 24 $500.43
82610 42 41 $496.67
84145 25 25 $495.64
0352U 597 571 $490.38
87269 43 43 $487.73
83921 49 39 $474.30
88304 34 29 $467.43
86870 13 12 $426.95
83721 58 55 $422.61
87593 15 13 $406.40
84436 95 90 $398.50
80177 41 37 $391.18
84445 13 13 $387.54
87272 31 31 $383.88
82088 14 12 $365.50
87799 15 12 $348.55
83521 25 13 $336.44
86677 48 42 $309.20
84478 63 36 $297.20
87075 41 40 $250.02
85014 145 129 $239.38
84080 35 33 $237.12
85245 12 12 $234.78
85247 12 12 $234.78
85240 24 24 $228.66
86039 32 31 $223.76
87350 20 17 $219.07
85379 30 28 $191.18
81025 27 26 $163.23
84207 15 12 $161.70
84202 14 12 $160.14
83010 20 16 $156.30
82166 84 82 $122.12
84466 13 12 $121.14
87328 13 12 $121.04
84075 38 37 $109.00
87329 13 12 $106.49
85004 14 12 $103.71
86255 28 12 $97.61
G0328 Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous 151 137 $95.31
80156 14 12 $90.35
82040 29 24 $73.77
85660 14 14 $57.29
G0499 Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result 149 140 $56.93
86880 13 12 $54.76
82525 12 12 $44.43
G0124 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, requiring interpretation by physician 339 333 $21.86
G0466 Federally qualified health center (fqhc) visit, new patient; a medically-necessary, face-to-face encounter (one-on-one) between a new patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit 127 125 $0.00